These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26080009)

  • 1. Elevated Serum GAD65 and GAD65-GADA Immune Complexes in Stiff Person Syndrome.
    Gu Urban GJ; Friedman M; Ren P; Törn C; Fex M; Hampe CS; Lernmark Å; Landegren U; Kamali-Moghaddam M
    Sci Rep; 2015 Jun; 5():11196. PubMed ID: 26080009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced display of conformational epitopes in the N-terminal truncated GAD65 isoform: relevance for people with stiff person syndrome or DQ8/8-positive Type 1 diabetes mellitus.
    Hampe CS; Radtke JR; Wester A; Carlsson A; Cedervall E; Jönsson B; Ivarsson SA; Elding Larsson H; Larsson K; Lindberg B; Neiderud J; Rolandsson O; Lernmark Å
    Diabet Med; 2019 Nov; 36(11):1375-1383. PubMed ID: 30264481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of CD4+ T cells specific for glutamic acid decarboxylase (GAD65) and proinsulin in a patient with stiff-person syndrome but without type 1 diabetes.
    Hänninen A; Soilu-Hänninen M; Hampe CS; Deptula A; Geubtner K; Ilonen J; Knip M; Reijonen H
    Diabetes Metab Res Rev; 2010 May; 26(4):271-9. PubMed ID: 20503259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome.
    Burbelo PD; Groot S; Dalakas MC; Iadarola MJ
    Biochem Biophys Res Commun; 2008 Feb; 366(1):1-7. PubMed ID: 18047830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence.
    Skorstad G; Hestvik AL; Torjesen P; Alvik K; Vartdal F; Vandvik B; Holmøy T
    Eur J Neurol; 2008 Sep; 15(9):973-80. PubMed ID: 18637036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus.
    Walikonis JE; Lennon VA
    Mayo Clin Proc; 1998 Dec; 73(12):1161-6. PubMed ID: 9868413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of in-vitro phenotypes of glutamic acid decarboxylase 65 autoantibodies in high-titre individuals.
    Chéramy M; Hampe CS; Ludvigsson J; Casas R
    Clin Exp Immunol; 2013 Mar; 171(3):247-54. PubMed ID: 23379430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder.
    Martinez-Hernandez E; Ariño H; McKeon A; Iizuka T; Titulaer MJ; Simabukuro MM; Lancaster E; Petit-Pedrol M; Planagumà J; Blanco Y; Harvey RJ; Saiz A; Graus F; Dalmau J
    JAMA Neurol; 2016 Jun; 73(6):714-20. PubMed ID: 27065452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an immunoassay for the simultaneous detection of GADA and ZnT8A in autoimmune diabetes using a ZnT8/GAD65 chimeric molecule.
    Trabucchi A; Bombicino SS; Sabljic AV; Marfía JI; Targovnik AM; Iacono RF; Miranda MV; Valdez SN
    Front Immunol; 2023; 14():1219857. PubMed ID: 37600804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.
    Achenbach P; Hawa MI; Krause S; Lampasona V; Jerram ST; Williams AJK; Bonifacio E; Ziegler AG; Leslie RD;
    Diabetologia; 2018 Jul; 61(7):1644-1649. PubMed ID: 29619531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients.
    Raju R; Foote J; Banga JP; Hall TR; Padoa CJ; Dalakas MC; Ortqvist E; Hampe CS
    J Immunol; 2005 Dec; 175(11):7755-62. PubMed ID: 16301686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome.
    Morgenthaler NG; Seissler J; Achenbach P; Glawe D; Payton M; Meinck HM; Christie MR; Scherbaum WA
    Autoimmunity; 1997; 25(4):203-11. PubMed ID: 9344328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A highly sensitive immunoassay resistant to autoantibody interference for detection of the diabetes-associated autoantigen glutamic acid decarboxylase 65 in blood and other biological samples.
    Waldrop MA; Suckow AT; Hall TR; Hampe CS; Marcovina SM; Chessler SD
    Diabetes Technol Ther; 2006 Apr; 8(2):207-18. PubMed ID: 16734550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to N-terminally Truncated GAD65(96-585): HLA Associations and Predictive Value for Type 1 Diabetes.
    Pöllänen PM; Härkönen T; Ilonen J; Toppari J; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e935-e946. PubMed ID: 34747488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
    Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
    J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome.
    Rizzi M; Knoth R; Hampe CS; Lorenz P; Gougeon ML; Lemercier B; Venhoff N; Ferrera F; Salzer U; Thiesen HJ; Peter HH; Walker UA; Eibel H
    PLoS One; 2010 May; 5(5):e10838. PubMed ID: 20520773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
    Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
    Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of recombinant glutamic acid decarboxylase in insect larvae and its application in an immunoassay for the diagnosis of autoimmune diabetes mellitus.
    Trabucchi A; Bombicino SS; Targovnik AM; Marfía JI; Sabljic AV; Faccinetti NI; Guerra LL; Iacono RF; Miranda MV; Valdez SN
    Sci Rep; 2019 Jan; 9(1):824. PubMed ID: 30696851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.
    Zhu Y; Qian L; Liu Q; Zou J; Zhou Y; Yang T; Huang G; Zhou Z; Liu Y
    Diabetes Metab J; 2020 Apr; 44(2):260-266. PubMed ID: 31769235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.
    Kim J; Namchuk M; Bugawan T; Fu Q; Jaffe M; Shi Y; Aanstoot HJ; Turck CW; Erlich H; Lennon V; Baekkeskov S
    J Exp Med; 1994 Aug; 180(2):595-606. PubMed ID: 7519242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.